» Articles » PMID: 11676987

ALS with Variable Phenotypes in a Six-generation Family Caused by Leu144phe Mutation in the SOD1 Gene

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 2001 Oct 26
PMID 11676987
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurological disorder. The mutations of Cu/Zn superoxide dismutase gene (SOD1) are responsible for familial ALS. We investigated a large family of Istro-Rumanian origin characterized by an autosomal dominant ALS occurring in 18 cases (three of which are still alive) throughout six generations.

Methods: Clinical data were available for nine patients from the 2nd generation onward, among which one contained the neuropathological details. The mean age at onset of the disease (+/-SD) was 57.3+/-8.9 years (range 49-72), while the duration of the disease spanned over a length of time equal to 4.9+/-1.96 years (range 1.5-7). The analysis of the coding region of SOD1 was done by PCR and direct sequencing. The SOD1 activity was measured by using the red and mononuclear cells belonging to three of the patients.

Results: The leu144phe mutation of SOD1 was identified in four patients while a normal sequence was found in five healthy related subjects. The molecular defect was responsible for a decrease in SOD1 activity. Most of patients in this family presented clinical manifestations of ALS (in particular, the lower limb onset variant) not as severe as typical ALS caused by other SOD1 mutations. However, one patient suffering from hyperthyroidism for 17 years, showed an early onset and a rapidly progressing ALS coupled with dementia.

Conclusions: We described a large family with a relatively not severe phenotype of ALS (due to a leu144phe SOD1 mutation) that was compromised in one patient by a concomitant hyperthyroidism.

Citing Articles

Updated Genetic Analysis of Japanese Familial ALS Patients Carrying Variants Revealed Phenotypic Differences for Common Variants.

Nishiyama A, Niihori T, Suzuki N, Izumi R, Akiyama T, Kato M Neurol Genet. 2024; 10(6):e200196.

PMID: 39502740 PMC: 11537459. DOI: 10.1212/NXG.0000000000200196.


Clinical and molecular features of patients with amyotrophic lateral sclerosis and mutations: a monocentric study.

Gagliardi D, Ripellino P, Meneri M, Del Bo R, Antognozzi S, Comi G Front Neurol. 2023; 14:1169689.

PMID: 37265463 PMC: 10230028. DOI: 10.3389/fneur.2023.1169689.


The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis.

Martinelli I, Zucchi E, Simonini C, Gianferrari G, Zamboni G, Pinti M Neural Regen Res. 2022; 18(7):1427-1433.

PMID: 36571338 PMC: 10075107. DOI: 10.4103/1673-5374.361535.


Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients.

Perciballi E, Bovio F, Rosati J, Arrigoni F, DAnzi A, Lattante S Antioxidants (Basel). 2022; 11(5).

PMID: 35624679 PMC: 9137766. DOI: 10.3390/antiox11050815.


Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia.

Marjanovic I, Selak-Djokic B, Peric S, Jankovic M, Arsenijevic V, Basta I J Neurol. 2017; 264(6):1091-1098.

PMID: 28444446 DOI: 10.1007/s00415-017-8495-y.